First Time Loading...

AVITA Medical Inc
NASDAQ:RCEL

Watchlist Manager
AVITA Medical Inc Logo
AVITA Medical Inc
NASDAQ:RCEL
Watchlist
Price: 8.3 USD -3.15% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. [ Read More ]

The intrinsic value of one RCEL stock under the Base Case scenario is 18.47 USD. Compared to the current market price of 8.3 USD, AVITA Medical Inc is Undervalued by 55%.

Key Points:
RCEL Intrinsic Value
Base Case
18.47 USD
Undervaluation 55%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
AVITA Medical Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling RCEL stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
AVITA Medical Inc

Provide an overview of the primary business activities
of AVITA Medical Inc.

What unique competitive advantages
does AVITA Medical Inc hold over its rivals?

What risks and challenges
does AVITA Medical Inc face in the near future?

Has there been any significant insider trading activity
in AVITA Medical Inc recently?

Summarize the latest earnings call
of AVITA Medical Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AVITA Medical Inc.

Provide P/S
for AVITA Medical Inc.

Provide P/E
for AVITA Medical Inc.

Provide P/OCF
for AVITA Medical Inc.

Provide P/FCFE
for AVITA Medical Inc.

Provide P/B
for AVITA Medical Inc.

Provide EV/S
for AVITA Medical Inc.

Provide EV/GP
for AVITA Medical Inc.

Provide EV/EBITDA
for AVITA Medical Inc.

Provide EV/EBIT
for AVITA Medical Inc.

Provide EV/OCF
for AVITA Medical Inc.

Provide EV/FCFF
for AVITA Medical Inc.

Provide EV/IC
for AVITA Medical Inc.

Show me price targets
for AVITA Medical Inc made by professional analysts.

What are the Revenue projections
for AVITA Medical Inc?

How accurate were the past Revenue estimates
for AVITA Medical Inc?

What are the Net Income projections
for AVITA Medical Inc?

How accurate were the past Net Income estimates
for AVITA Medical Inc?

What are the EPS projections
for AVITA Medical Inc?

How accurate were the past EPS estimates
for AVITA Medical Inc?

What are the EBIT projections
for AVITA Medical Inc?

How accurate were the past EBIT estimates
for AVITA Medical Inc?

Compare the revenue forecasts
for AVITA Medical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AVITA Medical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AVITA Medical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of AVITA Medical Inc compared to its peers.

Compare the P/E ratios
of AVITA Medical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing AVITA Medical Inc with its peers.

Analyze the financial leverage
of AVITA Medical Inc compared to its main competitors.

Show all profitability ratios
for AVITA Medical Inc.

Provide ROE
for AVITA Medical Inc.

Provide ROA
for AVITA Medical Inc.

Provide ROIC
for AVITA Medical Inc.

Provide ROCE
for AVITA Medical Inc.

Provide Gross Margin
for AVITA Medical Inc.

Provide Operating Margin
for AVITA Medical Inc.

Provide Net Margin
for AVITA Medical Inc.

Provide FCF Margin
for AVITA Medical Inc.

Show all solvency ratios
for AVITA Medical Inc.

Provide D/E Ratio
for AVITA Medical Inc.

Provide D/A Ratio
for AVITA Medical Inc.

Provide Interest Coverage Ratio
for AVITA Medical Inc.

Provide Altman Z-Score Ratio
for AVITA Medical Inc.

Provide Quick Ratio
for AVITA Medical Inc.

Provide Current Ratio
for AVITA Medical Inc.

Provide Cash Ratio
for AVITA Medical Inc.

What is the historical Revenue growth
over the last 5 years for AVITA Medical Inc?

What is the historical Net Income growth
over the last 5 years for AVITA Medical Inc?

What is the current Free Cash Flow
of AVITA Medical Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for AVITA Medical Inc.

Financials

Balance Sheet Decomposition
AVITA Medical Inc

Current Assets 104m
Cash & Short-Term Investments 89.1m
Receivables 7.9m
Other Current Assets 7m
Non-Current Assets 7.6m
PP&E 4.3m
Intangibles 487k
Other Non-Current Assets 2.8m
Current Liabilities 13.2m
Accounts Payable 3.8m
Accrued Liabilities 8.9m
Other Current Liabilities 539k
Non-Current Liabilities 49.4m
Long-Term Debt 39.8m
Other Non-Current Liabilities 9.6m
Efficiency

Earnings Waterfall
AVITA Medical Inc

Revenue
50.1m USD
Cost of Revenue
-7.6m USD
Gross Profit
42.6m USD
Operating Expenses
-85m USD
Operating Income
-42.4m USD
Other Expenses
7.1m USD
Net Income
-35.4m USD

Free Cash Flow Analysis
AVITA Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

RCEL Profitability Score
Profitability Due Diligence

AVITA Medical Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative Operating Income
28/100
Profitability
Score

AVITA Medical Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

RCEL Solvency Score
Solvency Due Diligence

AVITA Medical Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
42/100
Solvency
Score

AVITA Medical Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RCEL Price Targets Summary
AVITA Medical Inc

Wall Street analysts forecast RCEL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCEL is 27.34 USD with a low forecast of 21.21 USD and a high forecast of 42 USD.

Lowest
Price Target
21.21 USD
156% Upside
Average
Price Target
27.34 USD
229% Upside
Highest
Price Target
42 USD
406% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

RCEL Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

RCEL Price
AVITA Medical Inc

1M 1M
-48%
6M 6M
-12%
1Y 1Y
-41%
3Y 3Y
-59%
5Y 5Y
-69%
10Y 10Y
-15%
Annual Price Range
8.3
52w Low
8.3
52w High
20.79
Price Metrics
Average Annual Return -18.89%
Standard Deviation of Annual Returns 56.69%
Max Drawdown -92%
Shares Statistics
Market Capitalization 213.2m USD
Shares Outstanding 25 710 000
Percentage of Shares Shorted 2.84%

RCEL Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

AVITA Medical Inc Logo
AVITA Medical Inc

Country

United States of America

Industry

Biotechnology

Market Cap

213.2m USD

Dividend Yield

0%

Description

AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. The company is headquartered in Valencia California, California. The company went IPO on 2012-03-18. The firm is engaged in developing and commercializing a technology platform, which enables point-of-care autologous skin restoration for multiple unmet needs. The company provides treatment solutions derived from the regenerative properties of a patient’s own skin. Its RECELL Autologous Cell Harvesting System (RECELL) enables clinicians to prepare Spray-On Skin Cells, an autologous skin cell suspension, which is sprayed onto the patient to regenerate natural healthy skin. The RECELL System is a single use disposable, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators to achieve the disaggregation and delivery of skin cells. The platform technology of the RECELL System allows for the preparation and delivery of Spray-On Skin Cells, an autologous cellular suspension comprised of the patient’s own skin cells.

Contact

CALIFORNIA
Valencia California
28159 Avenue Stanford, Suite 220
+16613679170.0
https://www.avitamedical.com/

IPO

2012-03-18

Employees

-

Officers

CEO, President & Executive Director
Mr. James M. Corbett
Chief Financial Officer
Mr. David O'Toole
General Counsel, Chief Compliance Officer & Secretary
Ms. Donna Shiroma
Senior Vice President of Global Operations
Mr. David Fencil
Senior Vice President of Scientific & Medical Affairs
Dr. Katie Bush Ph.D.
Investor Relations Executive
Ms. Jessica Ekeberg
Show More
Senior Vice President of Global Marketing & Strategy
Ms. Debbie Garner
Senior Vice President of Human Resources
Mr. Rob Hall
Senior Vice President of Global Sales
Mr. Terry Bromley
Senior Vice President of Product Development & Program Management
Dr. Niraj Doshi J.D., P.M.P., Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one RCEL stock?

The intrinsic value of one RCEL stock under the Base Case scenario is 18.47 USD.

Is RCEL stock undervalued or overvalued?

Compared to the current market price of 8.3 USD, AVITA Medical Inc is Undervalued by 55%.